PTPRC and Miyoshi myopathy: CFA intra MM treatment increased CD45+ cell numbers > 14-fold at 1d post-CFA (t-test; Veh vs CFA; 2266 ± 77 vs 29,300 ± 6084, t = 4.443, df = 4; P = 0.011; n = 3).